COMMUNIQUÉS West-GlobeNewswire

-
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société
13/03/2018 - 17:54 -
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
13/03/2018 - 17:46 -
VALNEVA initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya
13/03/2018 - 17:46 -
Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference
13/03/2018 - 17:01 -
Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture
13/03/2018 - 16:40 -
Shire Applies to Cease to be a Reporting Issuer in Canada
13/03/2018 - 15:02 -
Immuron Progresses Discussions with Institutional Funds
13/03/2018 - 14:30 -
Gemphire Therapeutics to Announce Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15
13/03/2018 - 14:18 -
TrustedHealth Launches Global Network for Treatment of Life-Threatening Diseases, Presenting at World Health Organization
13/03/2018 - 14:16 -
Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
13/03/2018 - 14:02 -
NSS Labs Initiates Group Test Coverage of the Endpoint Detection and Response Market
13/03/2018 - 14:00 -
Predictive Technology Group Announces Presentations of Clinical Research Relating to the Role of Genetics in Endometriosis at the Society for Reproductive Investigation Meeting
13/03/2018 - 14:00 -
Exalenz Bioscience’s BreathID® Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
13/03/2018 - 14:00 -
Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer Award
13/03/2018 - 14:00 -
Precipio Settles Lawsuit with Crede Capital
13/03/2018 - 13:38 -
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
13/03/2018 - 13:30 -
Hydropothecary bolsters management team in preparation for recreational cannabis
13/03/2018 - 13:17 -
Hydropothecary renforce son équipe de direction en vue de la légalisation du cannabis à fins récréatives
13/03/2018 - 13:17 -
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018
13/03/2018 - 13:08
Pages